Catheter Precision, Inc.
VTAK
$2.12
$0.073.42%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 135.42% | 127.96% | 74.39% | 16.41% | -27.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 135.42% | 127.96% | 74.39% | 16.41% | -27.82% |
| Cost of Revenue | 80.00% | -12.50% | 120.00% | 57.14% | 66.67% |
| Gross Profit | 141.86% | 157.14% | 71.43% | 14.05% | -32.28% |
| SG&A Expenses | 2.46% | 6.19% | 31.21% | 13.52% | 4.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.88% | 8.54% | 33.40% | 17.43% | 3.21% |
| Operating Income | -5.67% | -4.45% | -32.11% | -17.48% | -4.73% |
| Income Before Tax | 45.00% | -51.85% | -78.28% | -271.75% | -113.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.11% | -29.34% | -51.21% | -741.26% | -113.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.36% | -21.07% | -51.21% | -741.26% | -113.80% |
| EBIT | -5.67% | -4.45% | -32.11% | -17.48% | -4.73% |
| EBITDA | -7.04% | -5.39% | -39.68% | -21.15% | -5.38% |
| EPS Basic | 95.53% | 93.23% | 90.04% | -19.54% | 29.06% |
| Normalized Basic EPS | 95.80% | 94.69% | 88.56% | 72.44% | 29.06% |
| EPS Diluted | 95.53% | 93.23% | 90.04% | -19.54% | 29.06% |
| Normalized Diluted EPS | 95.80% | 94.69% | 88.56% | 72.44% | 29.06% |
| Average Basic Shares Outstanding | 1,122.78% | 1,685.71% | 1,418.93% | 1,250.27% | 201.68% |
| Average Diluted Shares Outstanding | 1,122.78% | 1,685.71% | 1,418.93% | 1,250.27% | 201.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |